Navigation Links
STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine

Centocor Ortho Biotech Inc. discovered STELARA and has exclusive marketing rights to the product in the United States.  Janssen-Cilag companies have exclusive marketing rights in all countries outside of the United States.  STELARA is approved in 44 countries around the world including Canada, Europe and the United States for the treatment of moderate-to-severe plaque psoriasis.

Important Safety Information

STELARA™ is a prescription medicine that affects your immune system. STELARA™ can increase your chance of having serious side effects including:

Serious Infections

STELARA™ may lower your ability to fight infections and may increase your risk of infections. While taking STELARA™, some people have serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.

  • Your doctor should check you for TB before starting STELARA™ and watch you closely for signs and symptoms of TB during treatment with STELARA™.
  • If your doctor feels that you are at risk for TB, you may be treated for TB before and during treatment with STELARA™.

You should not start taking STELARA™ if you have any kind of infection unless your doctor says it is okay.

Before starting STELARA, tell your doctor if you think you have an infection or have symptoms of an infection such as:

  • fever, sweats, or chills
  • muscle aches
  • cough
  • shortness of breath
  • blood in your phlegm
  • '/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
2. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
3. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
4. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
5. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
8. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
9. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
10. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
11. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Post Your Comments:
(Date:6/2/2015)... ANGELES , June 2, 2015  CytRx Corporation ... company specializing in oncology, today announced that it has ... pending in the Delaware Court ... the Company,s current and former directors and officers, and ... The lawsuit, captioned In re CytRx Corp. Stockholder ...
(Date:6/2/2015)... -- Research and Markets ( ) has ... by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation ... Generator, ICE, X-ray)) & Indication (AF, VT, WPW) ... their offering. The global electrophysiology (EP) ... CAGR of 10.3% from 2014 to 2019 ...
(Date:6/2/2015)... , Minn. and WELLESLEY, Mass., June 2, 2015 /PRNewswire/ ... principal owner, Ampersand Capital Partners (Ampersand), announced the ... operation of Array BioPharma Inc. (Array).  Accuratus was ... Eagan, MN acquired Microtest ... GLP analytical and microbial testing services to the ...
Breaking Medicine Technology:CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 2CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 3CytRx Announces Settlement of Stockholder Derivative Lawsuit in Delaware 4Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 2Global Electrophysiology Market Report 2015-2019 - Product, Ablation Catheter, Lab Devices & Indication Analysis 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
(Date:6/2/2015)... 2015 ODU , a ... connector solutions and cable assemblies, is announcing its ... the US market. , ODU MINI-SNAP® ... The self- securing circular connector solution is ideal ... require significant customization such as: sensor devices, data ...
(Date:6/2/2015)... 2015 Visiting Nurse Association (VNA) ... home health care, hospice and community services, announced ... Steve Landers, MD, MPH, to the Visiting Nurse ... , VNAA is a national association based in ... driven, nonprofit providers of home and community-based healthcare, ...
(Date:6/2/2015)..., a popular online store selling celebrity inspired ... fashion cocktail dresses. The company carries more than 1000 ... suitable for a wide variety of summer events like ... make high quality trendy special occasion dresses ... satin, chiffon and cotton. Their products feature a wide ...
(Date:6/2/2015)... Consumer Reports, the world’s largest and ... commitment to help wipe out antibiotic-resistant bacteria or ... sicken about 2.25 million Americans each year and ... Control and Prevention. , The initiative kicks off ... participating in the White House Forum on Antibiotic ...
(Date:6/2/2015)... Denver, Colorado (PRWEB) June 02, 2015 ... it has tapped Jim Miller to become Amercanex’s ... fully electronic cannabis marketplace in which cultivators, wholesale ... exchange their inventories in a fully transparent intra-state ... and entrepreneur in the financial technology space, helping ...
Breaking Medicine News(10 mins):Health News:ODU Announces ODU MINI-SNAP® - Advanced Circular Connector Solution for Highly Customizable Applications 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 2Health News:Steve Landers, MD, MPH, President and CEO of VNA Health Group Appointed to VNAA Board of Directors 3Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Amercanex Names Jim Miller to CTO Position 2
... be a cause, expert says, , TUESDAY, July 28 (HealthDay ... a severe shortage of cardiothoracic surgeons at a time when ... procedures that fall under their purview, a new study predicts. ... and delays in care for people needing heart and lung ...
... , , , ... statewide prescription assistance program, announced today that it has partnered with the ... Nevada residents have access to the free drug card program. The Chamber ... work with members to develop additional card distribution sites. , , ...
... Chief Operating ... ... -- CRL Senior Living Communities announced today that Michael Munter, the company,s Chief ... Living Association (WALA) . , , , , ,A seasoned healthcare executive, Munter has strong ...
... , WASHINGTON, July 28 On Tuesday, ... the legislative lobbying arm of Family Research Council, will host ... proposed government takeover of the health care system. FRC Action ... the moral, ethical, and financial dangers of President Obama,s health care ...
... , Seniors Group Calls AARP,s Support of ... , WASHINGTON, July 28 Today the 400,000 ... by President Obama and his Congressional allies that propose to cut ... reform." Thair Phillips, the new president of RetireSafe, said AARP had ...
... 4,500 children in America are diagnosed with leukemia, according to ... the blood, it is the most common cancer in children. ... cases of childhood leukemia, so parents can still be hopeful ... Tel Aviv University,s Sackler School of Medicine and Sheba Medical ...
Cached Medicine News:Health News:Heart Surgeon Shortage Predicted 2Health News:Heart Surgeon Shortage Predicted 3Health News:Michael Munter Named to Wisconsin Assisted Living Association Board 2Health News:RetireSafe Blasts AARP for Supporting Plan to Pay for Health Care on the Backs of Seniors 2Health News:New drug for children with high-risk leukemia 2
... The new Finnpipette Focus ... specifically to combine ergonomics with ... interchangeable handle plate offers a ... sizes. The new shorter tip ...
... pipette is ideal for repeated ... Fixed volume FInnpipettes offer the ... other Finnpipette Digital pipettes: ... (1-40ul), Soft-touch tip ejection, Safety ...
Medicine Products: